OMEC.AI
Predicting Drug Success in Clinical Trials
Company Overview
Snapshot
Founded in September 2022 by Ori Shachar and Amir Harel, OMEC.AI had 0 employees and raised $2M across one funding round from 2 investors. The company was established with funding and support from AION Labs and Israel Innovation Authority.
Business overview
OMEC.AI develops an automated, data-focused solution designed to improve the success rates of clinical trials for pharmaceutical companies. The company's core technology provides a reliable assessment of a proposed drug's clinical trial-readiness, enabling better data-driven decisions in the pre-clinical process. OMEC.AI operates within the Health Tech & Life Sciences sector, specifically targeting the biopharmaceutical, artificial intelligence, clinical trials, drug development, and drug discovery markets.
Strategic signal
In September 2022, OMEC.AI was launched as the first AI startup to emerge from AION Labs, an innovation lab backed by major pharmaceutical and biotech giants including Pfizer and AstraZeneca. This signals strong industry validation and strategic backing for OMEC.AI's mission to enhance drug development through artificial intelligence, highlighting a significant collaborative effort to address challenges in clinical trial success rates.
Log in to access full profile ›Company Intelligence Q&A
- What is OMEC.AI's primary mission?
- OMEC.AI's mission is to help pharmaceutical companies improve their chances in clinical trials by enabling better data-driven decisions during the pre-clinical process.
- When was OMEC.AI founded and by whom?
- OMEC.AI was founded in September 2022 by Ori Shachar, who serves as Co-founder & CEO, and Amir Harel, Co-founder & CTO.
- What is OMEC.AI's current operational status?
- OMEC.AI is currently non-active, having ceased operations in July 2023.
- Which organizations supported the establishment of OMEC.AI?
- OMEC.AI was established with funding and support from AION Labs and Israel Innovation Authority.
- What kind of solution does OMEC.AI provide?
- OMEC.AI provides an automated, data-focused solution that assesses the clinical trial-readiness of proposed drugs, aiming to produce reliable evaluations for pharmaceutical companies.